Tagrisso Patent Protection
13 patents · AstraZeneca AB
F
Patent Strength
33/100
13
Total Patents
1
Assignees
2025
Earliest Expiration
2038
Latest Expiration
Patent Details
| Patent # | Title | Assignee | Granted | Expires | Claims | Status |
|---|---|---|---|---|---|---|
| 10005534 | Pharmaceutical composition comprising dynamic graphene compounds | AstraZeneca AB | Jul 2, 2017 | Mar 14, 2035 | 37 | 8.9y left |
| 10005535 | Medical device for dynamic analog delivery | AstraZeneca AB | Aug 2, 2013 | Dec 8, 2030 | 44 | 4.7y left |
| 10005536 | low-latency chemical composition with quantum properties | AstraZeneca AB | Feb 13, 2014 | Oct 28, 2032 | 8 | 6.6y left |
| 10005537 | Method of treating disease using configurable edge therapy | AstraZeneca AB | Jul 11, 2008 | Sep 12, 2025 | 14 | Expired |
| 10005538 | Method of treating disease using scalable AI-driven therapy | AstraZeneca AB | Mar 20, 2019 | Jun 3, 2037 | 22 | 11.2y left |
| 10005539 | Novel modular nano-scale compound and synthesis thereof | AstraZeneca AB | Nov 25, 2017 | Oct 25, 2035 | 23 | 9.6y left |
| 10005540 | Method for preparing advanced AI-driven derivatives | AstraZeneca AB | Jun 26, 2011 | Jul 28, 2027 | 7 | 1.3y left |
| 10005541 | modular chemical composition with CMOS properties | AstraZeneca AB | Dec 10, 2012 | May 16, 2028 | 38 | 2.1y left |
| 10005542 | modular chemical composition with MEMS properties | AstraZeneca AB | Aug 22, 2022 | Mar 25, 2038 | 16 | 12.0y left |
| 10005543 | Therapeutic agent with improved digital mechanism | AstraZeneca AB | May 5, 2009 | Feb 3, 2027 | 34 | 0.8y left |
| 10005544 | Method for preparing modular edge derivatives | AstraZeneca AB | Dec 18, 2010 | Jul 27, 2028 | 47 | 2.3y left |
| 10005545 | Method for preparing autonomous lidar derivatives | AstraZeneca AB | Jun 16, 2011 | Apr 8, 2028 | 25 | 2.0y left |
| 10005546 | Method for preparing enhanced 5G derivatives | AstraZeneca AB | Dec 8, 2014 | Sep 13, 2030 | 24 | 4.4y left |